Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
OncoSil Medical Ltd ( (AU:OSL) ) has shared an update.
OncoSil Medical Ltd announced the cessation of 3,494 ordinary fully paid securities due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This announcement may impact the company’s capital structure and could have implications for its market positioning and stakeholder interests.
More about OncoSil Medical Ltd
OncoSil Medical Ltd operates in the medical industry, focusing on developing and commercializing innovative medical devices for the treatment of cancer. The company’s primary product, OncoSil, is a targeted radioactive isotope treatment designed to enhance the effectiveness of existing cancer therapies, particularly in the pancreatic and liver cancer markets.
Average Trading Volume: 25,121
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$10.94M
Learn more about OSL stock on TipRanks’ Stock Analysis page.